Skip to main content
Contact Us
Subscribe
E-Edition
67°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Relay Therapeutics Inc
(NQ:
RLAY
)
7.860
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19
Open
7.860
Bid (Size)
7.010 (1)
Ask (Size)
8.150 (2)
Prev. Close
7.860
Today's Range
7.860 - 7.860
52wk Range
5.700 - 12.14
Shares Outstanding
121,613,181
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
September 15, 2024
The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual...
Via
Talk Markets
Why Relay Therapeutics Plummeted by Nearly 14% Today
September 11, 2024
Investors weren't happy with the company's latest effort at capital-raising.
Via
The Motley Fool
Performance
YTD
-33.70%
-33.70%
1 Month
+8.41%
+8.41%
3 Month
+14.74%
+14.74%
6 Month
-1.87%
-1.87%
1 Year
-10.78%
-10.78%
More News
Read More
Why Relay Therapeutics (RLAY) Stock Is Down 17% Today
September 11, 2024
Via
Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
September 11, 2024
Via
Benzinga
GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
September 11, 2024
Via
Benzinga
Expert Ratings For Relay Therapeutics
August 07, 2024
Via
Benzinga
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
September 11, 2024
Via
Benzinga
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
September 10, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
September 10, 2024
Via
Benzinga
AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
September 10, 2024
Via
Talk Markets
This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
September 10, 2024
Via
Benzinga
Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone
September 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Relay Therapeutics Announces Proposed Public Offering of Common Stock
September 09, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
September 09, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
September 09, 2024
Via
Benzinga
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
September 09, 2024
Via
Benzinga
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
September 09, 2024
Via
Benzinga
US Stocks Higher; Dow Surges Over 200 Points
September 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
September 09, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
September 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
September 05, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
August 27, 2024
Via
Talk Markets
RLAY Stock Earnings: Relay Therapeutics Beats EPS for Q2 2024
August 06, 2024
Via
InvestorPlace
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
July 30, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.